aspirin has been researched along with piperidines in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (29.21) | 18.7374 |
1990's | 18 (20.22) | 18.2507 |
2000's | 30 (33.71) | 29.6817 |
2010's | 13 (14.61) | 24.3611 |
2020's | 2 (2.25) | 2.80 |
Authors | Studies |
---|---|
Debelic, M; Radielovic, P; Wuethrich, B | 1 |
Wüthrich, B | 1 |
Igarashi, T; Morishima, Y; Shibano, T; Tanaka, T; Watanabe, K; Yasuoka, M | 1 |
Bezek, S; Durisová, M; Kállay, Z; Kukan, M; Laginová, V; Scasnár, V; Svoboda, V; Trnovec, T | 1 |
Kienast, J; Verstraete, M | 1 |
Chap, H; Douste-Blazy, L; Hullin, F; Pascal, M; Ragab-Thomas, JM; Sepulchre, C | 1 |
Buyniski, JP; Cavanagh, RL | 1 |
Borella, L; Failli, A; Grimes, D; Mir, GN; Rimele, TJ; Russell, J | 1 |
Hladovec, J | 2 |
Kimura, Y; Nakase, H; Watanabe, K | 1 |
Hamada, K; Okada, Y; Sekiguchi, H; Taga, F | 1 |
Dodge, JA; Hamdi, I | 1 |
Burton, JA; Ferguson, D; Lindsay, RM; McNicol, GP; Prentice, CR | 1 |
Towne, JC; Williams, CS; Williams, MW; Williford, EA | 1 |
Bennert, C; Berger, E; Jäger, W; Kauschmann, R; Kutschera, J; Pietsch, U; Riese, W; Wendeberg, H | 1 |
Riethe, P; Wilske, E | 1 |
Doenicke, A; Konrad, T; Kugler, J; Laub, M; Wittmann, R | 1 |
Emele, JF; Shanaman, JE | 1 |
Czerniawska-Mysik, G; Kuklinski, P; Serwonska, M; Szczeklik, A | 2 |
Dugdale, M; Johnson, RW; Lasslo, A; Naylor, JL; Quintana, RP | 1 |
Caro-Paton Gómez, A; Casas Carnicero, J; Dueñas Laita, A; Fernández de la Gandara, F | 1 |
Blackett, A; Brion, N; Turner, P | 1 |
Johnson, N; Leeling, J; Muni, I | 1 |
Montero, MJ; Palacios, B; Román, LS; Sevilla, MA | 1 |
Hamada, K; Nishino, K; Sekiguchi, H; Taga, F | 1 |
Morishima, Y; Shibano, T; Shibutani, T; Tanaka, T; Watanabe, K; Yasuoka, M | 1 |
Aronowski, J; Grotta, JC; Strong, R | 1 |
Grip, L; Mattsson, C; Rydén, L; Sjöquist, PO; Uriuda, Y; Wang, QD | 1 |
Börjesson, I; Elg, M; Gustafsson, D; Lenfors, S; Teger-Nilsson, AC | 1 |
Bernat, A; Herbert, JM; Hoffmann, P; Savi, P | 2 |
Bernat, A; Herault, JP; Herbert, JM; Peyrou, V; Savi, P | 1 |
Hatori, N; Mattsson, C; Nordlander, R; Rydén, L; Sjöquist, PO; Uriuda, Y; Wang, QD | 1 |
Christian, BJ; Lin, YS; Modi, NB; Reynolds, T; Shaheen, A | 1 |
Hotta, K; Ichikawa, T; Ishihara, K; Ivanov, C; Klouchek, E; Krushkov, I; Marazova, K; Popov, A | 1 |
Bina, S; Hart, J; Jing, M; Ledvina, MA; Muldoon, S | 1 |
Newby, LK | 1 |
Kanamaru, M; Kozawa, O; Matsuno, H; Nagashima, S; Uematsu, T | 1 |
Ayukawa, O; Kariyazono, H; Moriyama, Y; Nakamura, K; Shinkawa, T; Taira, A; Toyohira, H; Yamada, K; Yamaguchi, T; Yamashita, T; Yotsumoto, G | 1 |
Hamm, CW; Heeschen, C | 1 |
Birnböck, H; Chung, J; Ensor, H; Ertel, SI; Lausecker, B; Machin, SJ; MacKie, IJ; Wittke, B | 1 |
Breddin, HK; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Mahnel, R; Westrup, D | 1 |
Modi, NB; Novotny, W; Reimann, JD | 1 |
Bernat, A; Herbert, JM; Lalé, A; Roque, C; Savi, P; Zamboni, G | 1 |
McGuire, DK; Newby, LK | 2 |
Altman, DG | 1 |
Verheugt, FW | 1 |
Bari, M; Del Principe, D; Finazzi-Agrò, A; Giuliani, E; MacCarrone, M; Menichelli, A | 1 |
Bhatt, DL; Chew, DP; Sapp, S; Topol, EJ | 1 |
Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL | 1 |
Armstrong, PW; Califf, RM; Cantor, WJ; Christenson, RH; Hasselblad, V; Moliterno, DJ; Newby, LK; Ohman, EM; Topol, EJ; Tuttle, RH | 1 |
Aylward, PE; Bhapkar, MV; Califf, RM; Dimas, AP; Klein, WW; Kristinsson, A; McGuire, DK; Moliterno, DJ; Newby, LK; Verheugt, FW; Weaver, WD | 1 |
McRae, T; Orazem, J; Reichman, WE; Relkin, NR | 1 |
Amarenco, P; Califf, RM; Davis, S; Diener, HC; Easton, D; Ferguson, J; Fitzgerald, D; Graffagnino, C; Granett, J; Harrington, RA; Koudstaal, PJ; Pieper, K; Shuaib, A; Sigmon, K; Theroux, P; Topol, EJ; Vallee, M; Van de Werf, F; Willerson, JT | 1 |
Berger, PB; Bhapkar, MV; Califf, RM; Harrington, RA; Moliterno, DJ; Newby, LK; Ohman, EM; Tolleson, TR; Topol, EJ; Van de Werf, F; Verheugt, FW; White, HD | 1 |
LASAGNA, L; PEARSON, JW | 1 |
Tendera, M; Wojakowski, W | 1 |
Bhapkar, MV; Califf, RM; Graffagnino, C; Kassem-Moussa, H; Mahaffey, KW; Newby, LK; Sila, CA; Simes, RJ; Tasissa, G; White, HD | 1 |
Armstrong, PW; Califf, RM; Granger, CB; Lee, KL; Newby, LK; Simes, RJ; Van de Werf, F; White, HD | 1 |
Alexander, KP; Bhapkar, MV; Bushnell, CD; Califf, RM; Newby, LK; Parsons, E; Shah, SH; White, HD | 1 |
Badenhorst, HE; Daya, S; Maharaj, DS; Malan, SF; van Dyk, S | 1 |
Schaerlig, E | 1 |
Aoki, T; Furuichi, Y; Maeda, M; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S | 1 |
Aboul-Enein, HY; Nakashima, K; Nishiwaki, J; Ohwaki, Y; Wada, M; Yamane, T | 1 |
Matsuda, H; Nagatomo, A; Ochi, M; Yoshikawa, M | 1 |
Alexander, KP; Armstrong, PW; Aylward, PE; Bhapker, MV; Califf, RM; Hochman, JS; Newby, LK; Pfisterer, M; Van de Werf, F; White, HD; Wong, CK | 1 |
WINDER, CV | 1 |
Menezes-de-Lima, O; Pamplona, FA; Takahashi, RN | 1 |
Abdellatif, KR; Chowdhury, MA; Das, D; Dong, Y; Huang, Z; Knaus, EE; Rahman, M; Suresh, MR; Velázquez, CA; Yu, G | 1 |
Filaferro, M; Frigeri, C; Pini, LA; Ruggieri, V; Sandrini, M; Vitale, G | 1 |
Barrett, F; Keown, OP; Leslie, SJ; Macrury, SM; Megson, IL; Neilson, I; Wainwright, CL; Winterburn, TJ | 1 |
Asaka, M; Imai, A; Kamada, G; Kato, M; Nakagawa, M; Nakagawa, S; Nishida, U; Ono, S; Shimizu, Y; Yamamoto, K; Yoshida, T | 1 |
Asano, N; Furuya, A; Ikemoto, K; Makino, K; Nonaka, A; Suzuki, S; Tamaki, F | 1 |
Azhar, KF; Haider, S; Miana, GA; Mushtaq, N; Naz, A; Nisa, M; Rasheed, H; Saify, ZS | 1 |
Ruella, M; Soubeyran, P | 1 |
Aggarwal, H; Barthwal, MK; Bihan, D; Dhankani, P; Dikshit, DK; Dikshit, M; Farndale, RW; Kumar, S; Misra, A; Pandey, CP; Prakash, P; Pugh, N | 1 |
Allahtavakoli, M; Kaeidi, A; Moghadam-Ahmadi, A; Rahmani, MR; Shamsizadeh, A | 1 |
Armanious, M; Chavez, JC; Emole, J; Fradley, MG; Gliksman, M; Lee, DH; McLeod, H; Pinilla-Ibarz, J; Rhea, I; Schabath, MB; Shah, B; Viganego, F; Walko, C; Welter-Frost, A | 1 |
Lin, FJ; Lin, SY; Wang, CC; Wei, Y | 1 |
Bako, HY; Ibrahim, MA; Ibrahim, S; Isah, MS | 1 |
Gao, B; Gao, W; Ji, Q; Wan, H; Xu, F; Zhang, X; Zhou, R | 1 |
8 review(s) available for aspirin and piperidines
Article | Year |
---|---|
Pharmacology of the interaction between platelets and vessel wall.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Dextrans; Diltiazem; Dipyridamole; Epoprostenol; Humans; Imidazoles; Ketanserin; Piperidines; Pyrazoles; Pyrazolones; Sulfinpyrazone; Sulfonamides; Thiophenes; Ticlopidine | 1986 |
Oral platelet glycoprotein IIb/IIIa inhibition.
Topics: Alanine; Angina, Unstable; Aspirin; Benzamidines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Syndrome; Treatment Outcome | 2000 |
Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial.
Topics: Administration, Oral; Aspirin; Clinical Trials, Phase III as Topic; Coronary Disease; Humans; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic | 2000 |
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.
Topics: Administration, Oral; Alanine; Aspirin; Benzamidines; Clinical Trials, Phase III as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Multicenter Studies as Topic; Myocardial Infarction; Oximes; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic | 2001 |
Aspirin in patients with coronary artery disease: is it simply irresistible?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents | 2001 |
Role of antiplatelet drugs in the prevention of cardiovascular events.
Topics: Aspirin; Benzamidines; Clopidogrel; Coronary Artery Disease; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Stroke; Ticlopidine; Treatment Outcome | 2003 |
Lessons learned from a clinical trial.
Topics: Aspirin; Biomedical Research; Coronary Disease; Drug Therapy, Combination; Drugs, Investigational; Human Experimentation; Humans; Interdisciplinary Communication; Multicenter Studies as Topic; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Professional Staff Committees; Quality of Health Care; Randomized Controlled Trials as Topic; Secondary Prevention | 2004 |
Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly.
Topics: Adenine; Aged; Aspirin; Diarrhea; Hemorrhage; Humans; Lymphoma, Mantle-Cell; Male; Neoplasm Staging; Piperidines; Pyrazoles; Pyrimidines | 2016 |
17 trial(s) available for aspirin and piperidines
Article | Year |
---|---|
Protective effect of ketotifen and disodium cromoglycate against bronchoconstriction induced by aspirin, benzoic acid or tartrazine in intolerant asthmatics.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aspirin; Asthma; Benzoates; Bronchial Spasm; Complement C1 Inactivator Proteins; Cromolyn Sodium; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Piperidines; Tartrazine; Thiophenes | 1979 |
Reduction of thrombus formation on dialyser membranes by aspirin and RA 233.
Topics: Aspirin; Blood Cell Count; Blood Coagulation; Blood Platelets; Clinical Trials as Topic; Drug Synergism; Ethanolamines; Factor V; Female; Heparin; Humans; Kidneys, Artificial; Male; Piperidines; Placebos; Plasminogen; Platelet Adhesiveness; Pyrimidines; Renal Dialysis; Thrombosis | 1972 |
[Analgetic effects on the stimulus threshold of the human tooth].
Topics: Administration, Oral; Amides; Analgesics; Analysis of Variance; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Differential Threshold; Drug Evaluation; Electric Stimulation; Fumarates; Humans; Pain; Phenacetin; Phenobarbital; Piperidines; Placebos; Propionates; Pyridines; Toothache | 1974 |
[Electroencephalographic determination of vigilance following DL-propiramfumarate].
Topics: Amides; Analgesics; Aspirin; Attention; Caffeine; Clinical Trials as Topic; Codeine; Drug Synergism; Electroencephalography; Electrooculography; Ethanol; Eye Movements; Female; Fumarates; Humans; Male; Phenacetin; Phenobarbital; Piperidines; Placebos; Promethazine; Propionates; Pyridines | 1974 |
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coron
Topics: Administration, Oral; Aged; Angina, Unstable; Aspirin; Double-Blind Method; Female; Humans; Male; Middle Aged; Odds Ratio; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence | 2000 |
Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin.
Topics: Adult; Aspirin; Drug Interactions; Humans; Male; Oximes; Piperidines; Platelet Aggregation Inhibitors; Prodrugs; Ticlopidine | 2000 |
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.
Topics: Adenosine Diphosphate; Administration, Oral; Adult; Anticoagulants; Area Under Curve; Aspirin; Bleeding Time; Cross-Over Studies; Drug Interactions; Female; Heparin; Humans; Male; Middle Aged; Oximes; Partial Thromboplastin Time; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Prothrombin Time; Receptors, Thrombin | 2000 |
Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
Topics: Aged; Aspirin; Cause of Death; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Neovascularization, Physiologic; Oximes; Piperidines; Treatment Failure | 2001 |
Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Creatine Kinase; Creatine Kinase, MB Form; Disease-Free Survival; Female; Heart Diseases; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Sensitivity and Specificity; Stents; Troponin I | 2002 |
A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Aspirin; Cholinesterase Inhibitors; Comorbidity; Donepezil; Female; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Piperidines; Risk Assessment; Vitamins | 2003 |
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aspirin; Benzodiazepines; Cerebrovascular Disorders; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Risk Assessment; Treatment Outcome | 2003 |
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
Topics: Acute Disease; Aspirin; Causality; Coronary Disease; Coronary Thrombosis; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Oximes; Piperidines; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Syndrome | 2003 |
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
Topics: Acute Disease; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Proportional Hazards Models; Recurrence; Risk Factors; Stroke | 2004 |
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Cardiovascular Agents; Evidence-Based Medicine; Female; Humans; Male; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors | 2007 |
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
Topics: Acetamides; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Phenylpropionates; Piperidines; Pyridines; Stomach Diseases; Treatment Outcome; Young Adult | 2010 |
Literature Commentary.
Topics: Aged; Aspirin; Humans; Ophthalmology; Piperidines; Pyridines; Pyrroles; Retrospective Studies; Spiro Compounds; Stroke | 2021 |
Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomi
Topics: Acarbose; Adult; Aspirin; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated Hemoglobin; Heart Disease Risk Factors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Prospective Studies; Treatment Outcome; Uracil | 2022 |
64 other study(ies) available for aspirin and piperidines
Article | Year |
---|---|
The protective effect of a new oral anti-asthma agent (ketotifen, HC 20--511) against experimentally induced bronchospasm (5 different models).
Topics: Acetylcholine; Aerosols; Antigens; Aspirin; Benzoates; Bronchial Spasm; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Physical Exertion; Piperidines; Placebos; Tartrazine; Thiophenes | 1978 |
Prevention by DV-7028, a selective 5-HT2 receptor antagonist, of the formation of coronary thrombi in dogs.
Topics: Animals; Aspirin; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Administration Schedule; Piperidines; Serotonin Antagonists; Triazines | 1991 |
Irradiation of the head by 60Co opens the blood-brain barrier for drugs in rats.
Topics: Animals; Aspirin; Blood-Brain Barrier; Brain; Carbamates; Chloramphenicol; Cobalt Radioisotopes; Cranial Irradiation; Diazepam; Etimizol; Male; Piperidines; Rats; Rats, Inbred Strains; Regression Analysis | 1990 |
Stimulation of 12-HETE production in human platelets by an immunomodulator, LF 1695. Evidence for activation of arachidonate liberation coupled to cyclo-oxygenase inhibition.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Adjuvants, Immunologic; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcimycin; Cyclooxygenase Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin | 1989 |
Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Bethanechol Compounds; Dogs; Dose-Response Relationship, Drug; Female; Food; Gastric Acid; Histamine H2 Antagonists; Pentagastrin; Piperidines; Ranitidine; Stomach Ulcer | 1989 |
Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Topics: Anesthesia; Animals; Anti-Ulcer Agents; Aspirin; Dimaprit; Dogs; Gastric Acid; Gastric Mucosa; Guinea Pigs; Heart Rate; Histamine H2 Antagonists; In Vitro Techniques; Macaca mulatta; Male; Muscle Contraction; Muscle, Smooth; Phenoxypropanolamines; Piperidines; Rats; Rats, Inbred Strains; Species Specificity; Thiadiazoles; Thiourea | 1988 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; Piperidines; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Time Factors | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; Piperidines; Pizotyline; Prenylamine; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1986 |
Effect of cilostazol on experimental cerebral infarction in rabbits.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Azoles; Brain; Cerebral Infarction; Cilostazol; Injections, Intravenous; Piperidines; Rabbits; Tetrazoles; Vasodilator Agents | 1986 |
[Effects of troxipide on acute gastric lesions in rats].
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Aspirin; Ethanol; Gastric Mucosa; Hydrochloric Acid; Immersion; Male; Piperidines; Rats; Stomach Diseases; Stress, Physiological; Tranexamic Acid | 1987 |
Toddler diarrhoea: observations on the effects of aspirin and loperamide.
Topics: Antidiarrheals; Aspirin; Child, Preschool; Cyclooxygenase Inhibitors; Diarrhea; Diarrhea, Infantile; Humans; Infant; Loperamide; Piperidines; Prostaglandins F | 1985 |
Clinical analgesic activity of dexoxadrol.
Topics: Analgesics; Arthritis; Aspirin; Codeine; Dioxoles; Drug Synergism; Humans; Neoplasms; Pain; Palliative Care; Piperidines | 1969 |
[The continuous measurement of platelet aggregation without the addition of aggregation inducers. II. Experimental results and testing of aggregation inducers].
Topics: Aspirin; Benzyl Compounds; Cycloheptanes; Dimethylamines; Ethanolamines; Fibrinogen; Humans; In Vitro Techniques; Morpholines; Photometry; Piperazines; Piperidines; Platelet Adhesiveness; Platelet Aggregation; Polysaccharides; Pyrimidines; Sulfuric Acids; Thiophenes | 1974 |
Analgesic acitivity of namoxyrate (2-[4-biphenylyl] butyric acid 2-dimethylaminoethanol salt).
Topics: Amino Alcohols; Analgesics; Animals; Aspirin; Biphenyl Compounds; Bradykinin; Butyrates; Codeine; Dextropropoxyphene; Female; Meperidine; Mice; Morphine; Phenols; Phenylbutazone; Piperidines; Quinones; Rats; Seizures | 1967 |
Inhibition by ketotifen of idiosyncratic reactions to aspirin.
Topics: Adult; Aspirin; Asthma; Bronchi; Bronchial Spasm; Drug Hypersensitivity; Female; Histamine H1 Antagonists; Humans; Ketotifen; Male; Middle Aged; Piperidines; Placebos; Thiophenes | 1980 |
Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Calcimycin; Calcium; Calcium Channel Blockers; Carbamates; Chlorpromazine; Gallic Acid; Humans; In Vitro Techniques; Piperidines; Platelet Aggregation; Propranolol; Thrombin | 1984 |
[Changes in water, glucose, and electrolyte transport in the rat intestine "in vivo" after intraluminal injection of loperamide and aspirin].
Topics: Animals; Aspirin; Biological Transport; Electrolytes; Glucose; Intestine, Small; Loperamide; Male; Piperidines; Rats; Rats, Inbred Strains; Water | 1983 |
Recovery of acetylsalicylic acid and indalpine (LM 5008) after buccal partitioning.
Topics: Absorption; Aspirin; Cheek; Chemistry, Pharmaceutical; Humans; Hydrogen-Ion Concentration; Kinetics; Mouth Mucosa; Piperidines | 1983 |
Influence of broperamole, a new antiinflammatory agent, on gastrointestinal microbleeding in the dog.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Dogs; Feces; Gastrointestinal Hemorrhage; Iron Radioisotopes; Male; Phenylbutazone; Piperidines; Time Factors | 1980 |
Inhibition of idiosyncratic reactions to aspirin by ketotifen.
Topics: Adult; Aspirin; Asthma; Bronchial Spasm; Drug Hypersensitivity; Humans; Ketotifen; Piperidines; Thiophenes | 1980 |
Aspirin or loperamide for childhood gastroenteritis.
Topics: Aspirin; Child; Gastroenteritis; Humans; Loperamide; Piperidines | 1980 |
JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Topics: Animals; Aspirin; Ethanol; Gastric Acid; Gastric Mucosa; Guinea Pigs; Histamine H2 Antagonists; In Vitro Techniques; Indomethacin; Male; Muscarinic Antagonists; Piperidines; Ranitidine; Rats; Rats, Wistar; Stomach Diseases | 1995 |
Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Cyanides; Duodenal Ulcer; Epirizole; Ethanol; Gastric Mucosa; Histamine H2 Antagonists; Hydrochloric Acid; Immersion; Intestinal Mucosa; Male; Phenylurea Compounds; Piperidines; Rats; Rats, Wistar; Stomach Ulcer; Stress, Psychological | 1993 |
Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs.
Topics: Animals; Aspirin; Blood Pressure; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Drug Synergism; Heart Rate; Heparin; Piperidines; Serotonin Antagonists; Triazines; Ventricular Function, Left | 1993 |
Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia.
Topics: Animals; Aspirin; Cardiovascular Agents; Cerebral Infarction; Cerebrovascular Disorders; Drug Therapy, Combination; Hemodilution; Hemoglobins; Male; Neuroprotective Agents; Piperidines; Rats; Rats, Inbred Strains; Reperfusion; Thiazoles | 1996 |
Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis.
Topics: Animals; Aspirin; Coronary Thrombosis; Disease Models, Animal; Female; Glycine; Heparin; Male; Piperidines; Swine; Thrombin | 1996 |
Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
Topics: Animals; Antithrombins; Arginine; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinolytic Agents; Glycine; Heparin; Male; Molecular Weight; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombolytic Therapy; Thrombophlebitis; Thrombosis | 1996 |
Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin.
Topics: Animals; Aspirin; Benzylamines; Clopidogrel; Hemodynamics; Hemostasis; Male; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Thiazoles; Thrombosis; Ticlopidine | 1997 |
Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Topics: Animals; Aspirin; Benzylamines; Blood Platelets; Cells, Cultured; Humans; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Thiazoles; Thrombin | 1998 |
Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.
Topics: Animals; Antithrombins; Aspirin; Blood Flow Velocity; Coronary Thrombosis; Glycine; Hemodynamics; Heparin; Myocardial Ischemia; Piperidines; Reperfusion Injury; Swine; Thrombolytic Therapy | 1998 |
Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein II/III antagonist.
Topics: Animals; Aspirin; Benzylamines; Bleeding Time; Carotid Artery Injuries; Collagen; Fibrinolytic Agents; Hemostasis; In Vitro Techniques; Jugular Veins; Male; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Thiazoles; Thrombocytopenia; Thrombosis | 1998 |
Pharmacokinetics and pharmacodynamics of sibrafiban (Ro 48-3657), an orally active IIb/IIIa antagonist, administered alone or in combination with heparin, aspirin, and recombinant tissue-type plasminogen activator in beagles.
Topics: Administration, Oral; Amidines; Animals; Aspirin; Bleeding Time; Dogs; Heparin; Heterocyclic Compounds; Male; Oximes; Partial Thromboplastin Time; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Tissue Plasminogen Activator | 1998 |
Effect of roxatidine bismuth citrate (MX1) against acetylsalicylic acid- and indomethacin-induced gastric mucosal damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Combinations; Drug Evaluation, Preclinical; Gastric Mucosa; Indomethacin; Male; Organometallic Compounds; Piperidines; Rats; Rats, Wistar; Stomach Ulcer | 1998 |
Endothelin plays a role in contractions of isolated pig pulmonary vessels induced by diaspirin cross-linked hemoglobin.
Topics: Animals; Aspirin; Endothelin Receptor Antagonists; Endothelin-1; Glycopeptides; Hemoglobins; Isometric Contraction; Muscle, Smooth, Vascular; Nitroarginine; Oligopeptides; Piperidines; Pulmonary Artery; Pulmonary Veins; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Vasoconstrictor Agents | 1999 |
Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYMPHONY)
Topics: Angina, Unstable; Aspirin; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Randomized Controlled Trials as Topic; Research Design; Syndrome; Treatment Outcome | 1999 |
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.
Topics: Animals; Aspirin; Biphenyl Compounds; Cricetinae; Fibrinolytic Agents; Heptanoic Acids; Male; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1999 |
Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cimetidine; Collagen; Famotidine; Female; Heterocyclic Compounds, 1-Ring; Histamine H2 Antagonists; Humans; In Vitro Techniques; Male; Middle Aged; P-Selectin; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Ranitidine; Structure-Activity Relationship | 1999 |
Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists.
Topics: Administration, Oral; Aspirin; Death, Sudden, Cardiac; Humans; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors | 2000 |
Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A.
Topics: Abciximab; Administration, Oral; Adult; Analysis of Variance; Antibodies, Monoclonal; Aspirin; Benzylamines; Bleeding Time; Clopidogrel; Drug Administration Schedule; Drug Interactions; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Male; Nephelometry and Turbidimetry; P-Selectin; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reference Values; Thiazoles; Ticlopidine | 2000 |
Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Aspirin; Benzylamines; Blood Flow Velocity; Blood Platelets; Carotid Arteries; Disease Models, Animal; Electric Stimulation; Female; Fibrinolytic Agents; Humans; Male; Oligopeptides; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Recombinant Proteins; Thiazoles; Thrombosis; Thrombospondins; Tissue Plasminogen Activator | 2000 |
Randomisation in the SYMPHONY trial.
Topics: Angina, Unstable; Aspirin; Double-Blind Method; Humans; Oximes; Piperidines; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 2000 |
How hot is inflammation in acute coronary syndrome?
Topics: Angina, Unstable; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Humans; Inflammation; Methylprednisolone; Oximes; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic | 2000 |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor.
Topics: Adenosine Diphosphate; Amidohydrolases; Arachidonic Acids; Aspirin; Biological Transport; Blood Platelets; Calcium Channel Blockers; Camphanes; Cannabinoid Receptor Modulators; Collagen; Cyclic AMP; Endocannabinoids; Glycerides; Humans; Hydrolysis; Inositol 1,4,5-Trisphosphate; Kinetics; Piperidines; Platelet Activation; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin; Time Factors | 2001 |
ACE inhibitor reduces cardiovascular events by 22%.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Diseases; Humans; Multicenter Studies as Topic; Myocardial Ischemia; Oximes; Piperidines; Platelet Aggregation Inhibitors; Ramipril; Randomized Controlled Trials as Topic | 2000 |
Early statin initiation and outcomes in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Angina, Unstable; Aspirin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Oximes; Piperidines; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2002 |
ANALGESIC AND PSYCHOTOMIMETIC PROPERTIES OF DEXOXADROL.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Biomedical Research; Dioxolanes; Drug Therapy; Female; Hallucinogens; Humans; Pain; Pharmacology; Piperidines; Placebos; Puerperal Disorders; Toxicology | 1965 |
Postmenopausal hormone use in women with acute coronary syndromes.
Topics: Aged; Aspirin; Attitude to Health; Coronary Disease; Estrogen Replacement Therapy; Female; Global Health; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Oximes; Piperidines; Platelet Aggregation Inhibitors; Postmenopause; Prevalence; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Survival Analysis; Time Factors; Treatment Outcome; Women's Health | 2004 |
Histamine-3 receptor antagonists reduce superoxide anion generation and lipid peroxidation in rat brain homogenates.
Topics: Animals; Antioxidants; Aspirin; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Histamine Agonists; Imidazoles; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Piperidines; Potassium Cyanide; Rats; Rats, Wistar; Receptors, Histamine H3; Superoxides; Thiourea | 2005 |
[Highlights from the American College of Cardiology Annual Scientific Session 2005: March 5-9, 2005, Orlando, Florida].
Topics: Aspirin; Cardiovascular Diseases; Cholesterol, LDL; Clopidogrel; Humans; Hypercholesterolemia; Obesity; Piperidines; Platelet Aggregation Inhibitors; Pyrazoles; Rimonabant; Stroke; Ticlopidine | 2005 |
Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonist.
Topics: Animals; Aspirin; Bleeding Time; Collagenases; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Heparin; Intracranial Hemorrhages; Male; Piperidines; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Recombinant Proteins; Tissue Plasminogen Activator; Whole Blood Coagulation Time | 2005 |
Interaction study of aspirin or clopidogrel on pharmacokinetics of donepezil hydrochloride in rats by HPLC-fluorescence detection.
Topics: Administration, Oral; Animals; Aspirin; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Clopidogrel; Donepezil; Drug Interactions; Fluorescence; Indans; Injections, Intraperitoneal; Male; Molecular Structure; Piperidines; Rats; Rats, Wistar; Ticlopidine | 2007 |
Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats.
Topics: Alkaloids; Ammonia; Animals; Armoracia; Aspirin; Benzodioxoles; Capsaicin; Dose-Response Relationship, Drug; Ethanol; Food Preservatives; Gastric Mucosa; Hydrochloric Acid; Indomethacin; Isothiocyanates; Male; NG-Nitroarginine Methyl Ester; Omeprazole; Piperidines; Polyunsaturated Alkamides; Prostaglandins; Rats; Rats, Sprague-Dawley; Ruthenium Red; Structure-Activity Relationship | 2007 |
Quantitative evaluation of analgetic action in guinea pigs; morphine, ethyl l-methyl-4-phenylpiperidine-4-carboxylate (demerol) and acetylsalicylic acid.
Topics: Analgesics; Aspirin; Guinea Pigs; Meperidine; Morphine; Piperidines; Salicylates | 1947 |
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Aspirin; Catalepsy; Central Nervous System Agents; Cyclooxygenase Inhibitors; Endocannabinoids; Lipoxins; Male; Mice; Models, Neurological; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Lipoxin; Rimonabant | 2010 |
Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Celecoxib; Crystallography, X-Ray; Cyclooxygenase 2 Inhibitors; Humans; Hydrogen-Ion Concentration; Ibuprofen; Inhibitory Concentration 50; Molecular Structure; Nitric Oxide; Nitric Oxide Donors; Piperidines; Prodrugs; Pyrazoles; Rats; Sheep; Structure-Activity Relationship; Sulfonamides | 2010 |
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats.
Topics: Analgesics; Animals; Aspirin; Chromatography, High Pressure Liquid; Frontal Lobe; Male; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin Plasma Membrane Transport Proteins | 2010 |
2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors.
Topics: Adolescent; Adult; Aged; Arachidonic Acids; Aspirin; Blood Platelets; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Coronary Artery Disease; Endocannabinoids; Glycerides; Humans; Indoles; Male; Middle Aged; Piperidines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazoles; Young Adult | 2010 |
[Low doses of ketamine have no effect on bispectral index during stable propofol-remifentanil anesthesia].
Topics: Acetaminophen; Anesthesia, General; Anesthetics, Intravenous; Aspirin; Chlorpheniramine; Consciousness Monitors; Dextropropoxyphene; Drug Combinations; Female; Humans; Ketamine; Piperidines; Remifentanil | 2012 |
Investigation of piperidine derivatives in ex vivo models of pain and platelet aggregation.
Topics: Analgesics; Animals; Aspirin; Female; Humans; Inhibitory Concentration 50; Male; Mice; Pain; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Receptors, Opioid; Structure-Activity Relationship; Thromboxane A2 | 2012 |
Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro.
Topics: Animals; Aspirin; Blood Coagulation; Chlorides; Clopidogrel; Dose-Response Relationship, Drug; Ferric Compounds; Fibrinolytic Agents; Male; Mice; Piperidines; Platelet Adhesiveness; Platelet Aggregation; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thrombosis | 2018 |
Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke.
Topics: Animals; Aspirin; Behavior, Animal; Benzodioxoles; Brain; Brain Edema; Brain Ischemia; Disease Models, Animal; Edema; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-10; Male; Matrix Metalloproteinase 9; Mice; Monoacylglycerol Lipases; Neuroprotective Agents; Piperidines; Stroke; Tumor Necrosis Factor-alpha | 2018 |
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy.
Topics: Adenine; Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Aspirin; Atrial Fibrillation; Atrial Flutter; Female; Humans; Hypertension; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Multivariate Analysis; Piperidines; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Risk Factors; Waldenstrom Macroglobulinemia | 2019 |
Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study.
Topics: Aged; Aspirin; Carbamates; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Piperidines; Platelet Aggregation Inhibitors | 2019 |
Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes.
Topics: Animals; Aspirin; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Interleukin-6; Janus Kinases; Male; NF-kappa B; Piperidines; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Serum Amyloid A Protein; Signal Transduction; STAT Transcription Factors; Tumor Necrosis Factor-alpha | 2019 |